Lyme Disease Vaccine Study for Children age 5 or older and Healthy Adults

Lyme disease is a tick-borne illness that can cause serious long-term symptoms if left untreated Currently, there are no approved vaccines available to prevent Lyme disease in people exposed to ticks that carry Lyme disease. This clinical trial will evaluate if an investigational (study) vaccine is safe and effective in preventing Lyme disease. This study may be an option for healthy adults and children over 5 who live in areas where ticks that carry Lyme disease are found and frequently participate in activities that may put them in contact with ticks: Outdoor occupations such as landscaping, forestry, or wildlife and parks management Frequent outdoor recreational activities such as hiking, camping, fishing, hunting, or gardening Living in or frequently visiting wooded areas, tree lines, tall grass, open fields, lake sides, or riversides Owning a pet that may return from outdoors with attached ticks These are not the only eligibility criteria for this clinical research study. A clinical research team member will help determine if this
Read more.

Covid Vaccine Study for Babies age 3 months to <6 months

At this time, there is  no approved or authorized Covid-19 protection for babies under 6 months old, leaving them vulnerable at daycare, at family functions, and even at home as older siblings head back to school. The vaccine being evaluated in the BabyCOVE Study is Moderna’s “bivalent” (addressing 2 viral strains at the same time) investigational COVID-19 vaccine. It is being evaluated at 2 dosing levels to find out which is the safest and most effective dose for infants.
Read more.

Covid Vaccine Research Study for Children 6 months to 5 years old

Your child could be part of important research for an investigational COVID-19 variant vaccine. We’re enrolling children between 6 months and 5 years old who have not yet received any COVID-19 vaccines to join the ROVER Study to help researchers continue to find solutions to the COVID-19 pandemic.
Read more.

Mono Vaccine Research study

We're looking for healthy volunteers to participate in a clinical trial of an investigational mRNA vaccine to  protect against mono. Must be age 18 to 30 other criteria apply Volunteers are compensated for participation
Read more.

RSV Vaccine Co-administered with Influenza Vaccine Age 65 or older

RSV (respiratory syncytial virus) is a common respiratory virus that infects the lungs and breathing passages. People most frequently associate RSV with the risk it brings to young children, but not many know the high risk it poses for older adults. RSV is the second leading cause of significant respiratory tract illnesses in adults. RSV causes about 177,000 hospitalizations and 14,000 deaths in the US annually in those over the age of 65. To join this trial, you must be: Age 50 or older In good health Primarily responsible for self-care ( do not require a caretaker) Other criteria apply  
Read more.

RSV Vaccine Study Age 50 or older

Are you age 60 or older? You could be at risk for acute respiratory disease if you become ill with RSV. (Respiratory Syncytial Virus) Consider participating in an RSV vaccine study to potentially help prevent this serious illness. Volunteers must be: Age 50 or older Primarily responsible for self care (do not require a caretaker) In good health-Certain well controlled chronic diseases may be permissible Other criteria apply No insurance is required to participate and volunteers will be compensated for their time.
Read more.

CMV (cytomegalovirus) Vaccine Study

We are looking for  volunteers to participate in a research study for a vaccine against CMV Eligibility criteria: A woman between 16-40 years of age In good health Not pregnant or planning on becoming pregnant within the next 9 months For women over age 20:  In close contact with at least one child 5 years of age or younger for at least hours a week Other criteria will apply. No insurance is required to participate and volunteers will be compensated for their time.
Read more.